ArticleTransplantation proceedings2026
Association of Moderate Coronary Artery Disease Burden With Major Adverse Cardiovascular Events Following Kidney Transplantation.
Article in Transplantation proceedings, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Coronary artery disease (CAD) is the leading cause of mortality in kidney transplant (KT) recipients. While KT candidates with severe CAD often undergo revascularization, the impact of moderate, nonobstructive CAD remains unclear. In this retrospective study of KT recipients at Saint Louis University Hospital (2015-2024), we evaluated patients who underwent pre-transplant invasive coronary angiography but had no stenosis >70% and did not receive coronary revascularization before transplant. Patients were grouped by the number of coronary vessels with moderate 50% to 70% stenosis: none (0V), 1-2-vessel (1-2V), and 3-vessel (3V) disease. The primary outcome was post-KT major adverse cardiovascular events (MACE), a composite of cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina, hospitalization for heart failure, arrhythmia, percutaneous coronary intervention or coronary artery bypass surgery Among 174 KT patients who underwent pre-KT coronary angiography and had moderate CAD, MACE occurred in 9.4%, 14.8%, and 37.5% of the 0V, 1-2V, and 3V groups. After adjustment, 3V disease was associated with a higher risk of MACE (hazard ratio 3.30, 95% CI:1.27-8.56). Left anterior descending artery (LAD) involvement was also independently associated with MACE (P = .004).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.